We included patients older than @ years with previously untreated metastatic colorectal cancer , with stable disease or better after induction treatment with six @-weekly cycles of capecitabine , oxaliplatin , and bevacizumab ( CAPOX-B ) , WHO performance status of @ or @ , and adequate bone marrow , liver , and renal function .